Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban

59Citations
Citations of this article
162Readers
Mendeley users who have this article in their library.

Abstract

The new oral anticoagulants dabigatran etexilate (Pradaxa), rivaroxaban (Xarelto), and apixaban (Eliquis) have predictable pharmacokinetic and pharmacodynamic profiles and are alternatives to warfarin. However, many physicians are wary of these drugs, since there is limited evidence on how to manage bleeding in patients taking them, and since no specific antidote is known to reverse their anticoagulant effect. Management requires careful adherence to first principles of bleeding care. Unapproved and untested reversal strategies may be required in patients with life-threatening bleeding.

References Powered by Scopus

Dabigatran versus warfarin in patients with atrial fibrillation

9792Citations
N/AReaders
Get full text

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

8164Citations
N/AReaders
Get full text

Apixaban versus warfarin in patients with atrial fibrillation

7723Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

589Citations
N/AReaders
Get full text

Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis

75Citations
N/AReaders
Get full text

Administration of 4-factor prothrombin complex concentrate as an antidote for intracranial bleeding in patients taking direct factor Xa inhibitors

72Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Fawole, A., Daw, H. A., & Crowther, M. A. (2013). Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban. Cleveland Clinic Journal of Medicine, 80(7), 443–451. https://doi.org/10.3949/ccjm.80a.13025

Readers over time

‘13‘14‘15‘16‘17‘18‘19‘20‘21‘22‘23‘24‘2509182736

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 48

50%

Researcher 22

23%

Professor / Associate Prof. 19

20%

Lecturer / Post doc 7

7%

Readers' Discipline

Tooltip

Medicine and Dentistry 113

88%

Pharmacology, Toxicology and Pharmaceut... 10

8%

Nursing and Health Professions 3

2%

Agricultural and Biological Sciences 3

2%

Save time finding and organizing research with Mendeley

Sign up for free
0